Short Interest in CBD Life Sciences Inc. (OTCMKTS:CBDL) Expands By 20.2%

CBD Life Sciences Inc. (OTCMKTS:CBDL) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 159,300 shares, an increase of 20.2% from the January 15th total of 132,500 shares. Based on an average daily volume of 37,383,900 shares, the short-interest ratio is presently 0.0 days.

CBD Life Sciences Stock Up 25.0 %

Shares of CBD Life Sciences stock traded up $0.00 during trading on Friday, hitting $0.00. 39,669,626 shares of the company’s stock traded hands, compared to its average volume of 18,763,139. CBD Life Sciences has a 1 year low of $0.00 and a 1 year high of $0.03.

CBD Life Sciences Company Profile

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.